Prescription drug price transparency

The following resources are for reporting entities who may need assistance with prescription drug price transparency.

On this page

Want to stay up-to-date on prescription drug price transparency?

Sign up for notifications

Reporting entity resources (carriers, manufacturers, PBMs, PSAOs)

The following resources are for reporting entities who may need assistance.

The excel templates below are available as an aid if you are hand-keying data for submissions to the Drug Price Transparency program. These workbooks are programmed with simple rules that will help you avoid some common errors that can occur.

Important note about Excel version

We recommend using Microsoft Excel 2016 or earlier for the submission guides. Using Microsoft Excel 2019 can cause formatting issues when saving as a CSV file.

DPT login process

Reporting entities can log into HCA Support to enter their data for the DPT program. You will need a SecureAccess Washington (SAW) account to login.

Setting up a SAW account

Step-by-step instructions for accessing DPT reporting forms

Extensions

Use the extension form if you are not able to meet the due date of a required report and would like to request additional time. To access the extension form, follow the instructions for accessing DPT reporting forms. Once you have accessed the portal, you will see the DPT re-submission/extension option.

All

Carriers

Report year 2024 (effective September 1, 2025)

Manufacturers

Report year 2026 (effective September 1, 2025 through August 1, 2026)

Report year 2025 (effective September 1, 2024 through August 1, 2025)

Pharmacy Benefit Managers (PBM)

Report year 2024 (comments due March 1, 2026) Available February 1, 2026

Report year 2023 (due date March 1, 2025)

Pharmacy Services Administrative Organizations (PSAO)

Report year 2023 (effective September 1, 2024)

Background

In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).

Reports

Annual reports created by HCA to detail the current state of the program as the agency begins to receive drug pricing and cost data.

Contact

Program questions and information
Email: HCA Drug Price Transparency - general inquiry

Protections for insurance consumers and insurance industry oversight
Contact: Washington State Office of the Insurance Commissioner (OIC)